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ABSTRACT
An anion inhibition study of the b-class carbonic anhydrase, AgaCA, from the malaria mosquito Anopheles
gambiae is reported. A series of simple as well as complex inorganic anions, and small molecules known
to interact with CAs were included in the study. Bromide, iodide, bisulphite, perchlorate, perrhenate, per-
ruthenate, and peroxydisulphate were ineffective AgaCA inhibitors, with KIs> 200mM. Fluoride, chloride,
cyanate, thiocyanate, cyanide, bicarbonate, carbonate, nitrite, nitrate, sulphate, stannate, selenate, tellurate,
diphosphate, divanadate, tetraborate, selenocyanide, and trithiocarbonate showed KIs in the range of
1.80–9.46mM, whereas N,N-diethyldithiocarbamate was a submillimolar AgaCA inhibitor (KI of 0.65mM).
The most effective AgaCA inhibitors were sulphamide, sulphamic acid, phenylboronic acid and phenylar-
sonic acid, with inhibition constants in the range of 21–84mM. The control of insect vectors responsible of
the transmission of many protozoan diseases is rather difficult nowadays, and finding agents which can
interfere with these processes, as the enzyme inhibitors investigated here, may arrest the spread of these
diseases worldwide.
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1. Introduction
Malaria is a tropical disease transmitted mainly by mosquitoes of
the genus Anopheles. The disease itself is caused by parasites of
the genus Plasmodium, of which five species affect human red
blood cells: P. falciparum, P. ovale, P. vivax, P. knowlesi and P.
malariae. Of these P. falciparum causes the most severe infection.
Malaria causes non-specific symptoms of which most common are
fever and headache, and in severe cases the disease may lead to
death1.
Carbonic anhydrases (CAs, EC 4.2.1.1) are enzymes that catalyse
the reversible hydration reaction of carbon dioxide according to
the following reaction2: CO2þH2O$HCO3þHþ. CAs are typic-
ally zinc-containing metalloenzymes, but the f form uses cadmium
or zinc (in an inter-exchangeable manner), as an alternative metal
cofactor3,4. In addition, c-CAs may contain iron(II) within the active
site, at least in some anaerobic Archaea5,6. The reaction catalysed
by CAs is crucial in the regulation of acid–base balance in organ-
isms. Additionally, this reaction participates in removing carbon
dioxide out of tissues, takes part in biosynthetic reactions such as
gluconeogenesis and ureagenesis, and is involved in many other
physiological processes as well2. Seven classes of carbonic anhy-
drases have been identified: the a, b, c, d, f, g and h-CAs7. Of
these, b-CAs appear to be the family with the widest distribution7.
They have been described from various groups of organisms
including the Bacteria and Archaea domains as well as in all spe-
cies of plants and some fungi among Eukarya8. In addition, our
previous studies suggested the widespread occurrence of at least
one single-copy of a b-CA gene among animal species distinct
from chordates9.
b-CAs were first reported from two invertebrate species: the
fruit fly Drosophila melanogaster and the worm Caenorhabditis ele-
gans9,10. Additionally, a b-CA was characterised from the unicellu-
lar parasite Leishmania donovani chagasi which is one of the
causative agents for visceral leishmaniasis11. Previously two a-CAs
have been characterised from the mosquito Anopheles gam-
biae12,13. Despite the recent finding that Leishmania parasites
encode b-CAs, some protozoan parasites possess only a- or g-CAs.
For example, P. falciparum seems to encode only the g-CAs14. The
exact expression pattern of b-CAs in protozoan organisms is cur-
rently unclear, even though a previous report suggested the pres-
ence of this enzyme family in a number of protozoans and
metazoans14c. Recently, a-CA was characterised from unicellular
protozoa responsible of Chagas’ disease, Trypanosoma cruzi15.
b-CAs are not present in vertebrates, which may lead to the
design of b-CA-specific inhibitors that could be used against inver-
tebrate pathogens and pathogen vectors with minimal side effects
on vertebrate species. However, no such inhibitors have been
reported so far. We performed sequence searches in the genomes
of different pathogen vectors and found out that Anopheles gam-
biae encodes for one b-CA in addition to several a-CAs. The aim of
this study was to characterise further the b-CA, AgaCA, from mal-
aria mosquito Anopheles gambiae, which is one of the most
important malaria vector organisms1. Kinetic and anion inhibition
studies with a large set of inhibitors were carried out to character-
ise its catalytic activity and inhibition profile, considering the fact
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that we have reported earlier only the sulphonamide inhibition
profile of this enzyme16.
2. Materials and methods
2.1. Construction of b-CA fusion protein
Anopheles gambiae cDNA was obtained from Professor Michael
Lehane (Liverpool School of Tropical Medicine, UK). The b-CA gene
was retrieved from NCBI protein databases using Blast17, http://
blast.ncbi.nlm.nih.gov/Blast.cgi. The full-length b-CA gene was
identified and amplified from cDNA by PCR using PhusionTM Hot
Start High Fidelity DNA Polymerase (Finnzymes, Espoo, Finland).
The detailed PCR method has been described previously by our
group16. The PCR product band was separated from the gel and
dissolved using IllustraTM GFX PCR DNA and GEL Band Purification
Kit (GE Healthcare Life Sciences, Buckinghamshire, UK). Validity of
the PCR product was verified by sequencing.
For recombinant protein production, the b-CA gene was con-
structed and cloned into the pFastBac1TM vector. The forward pri-
mer used in the initial amplification of the b-CA gene was 50-
CGCGGATCCATGGAGCGTATATTGCGAGGC-30 (F2), and the reverse
primer was 50-GCCCTCGAGTTAATGGTGGTGATGGTGGTGGGAACC-
ACGGGGCACCAGCGAATAGTATCGCCGTACCTC-30 (R2). The latter
primer contains nucleotide repeats to create the C-terminal poly-
histidine tag with six histidines. In addition, the forward primer
contained the restriction site for BamHI and the reverse primer for
XhoI. The reverse primer also contained the nucleotide sequence
encoding thrombin cleavage site. The PCR program was as follows:
98 C for 30 s; then 35 cycles of 98 C for 10 s, 62 C for 15 s, and
62 C for 30 s, and finally 72 C for 5min.
The PCR product was run on an agarose gel, and the obtained
band was purified. pFastBacTM1 plasmid (Invitrogen, Carlsbad, CA)
and the PCR product were digested atþ37 C overnight with
BamHI and XhoI restriction enzymes (New England Biolabs,
Ipswich, MA). The digested plasmid and PCR product containing
full-length recombinant A. gambiae b-CA gene were purified and
then ligated overnight at þ4 C using T4 DNA ligase (New
England Biolabs). The ligated product was transformed into TOP10
bacteria (Invitrogen, Helsinki, Finland). Overnight cultures (8ml)
were made from these colonies, and plasmids were purified using
a QIAprep Spin Miniprep KitTM (Qiagen, Hilden, Germany). The
construction of baculoviral genomes encoding the recombinant
proteins has been described previously18.
2.2. Production of A. gambiae b-CA
The Sf9 insect cells were grown in Insect-Xpress protein-free cell
culture medium (Lonza, Verviers, Belgium) in an orbital shaker at
27 C (125 rpm) for 3 d after infection. Protein purification was per-
formed after centrifugation (5000 g, 20 C, 8min) from the super-
natant. Purification was performed using the ProtinoVR Ni-NTA
Agarose (from Macherey-Nagel, Munich, Germany) under native
binding conditions with wash and elution buffers made according
to the manufacturer's instructions. The purification procedure per
400ml of insect cell medium was as follows: 3 L of native binding
buffer (50mM NaH2PO4, 500mM NaCl, pH 8.0) and 8ml of the
nickel-chelating agarose were added to the medium, and the His-
tagged protein was then allowed to bind to the resin on a mag-
netic stirrer at 25 C for 3 h. The resin was washed with 40þ 20ml
of washing buffer (50mM NaH2PO4, 500mM NaCl, 20mM imid-
azole pH 8.0). The protein was then eluted with elution buffer
(50mM NaH2PO4, 500mM NaCl, 250mM imidazole, pH 8.0). After
this, the protein was transferred to 50mM Tris-HCl, pH 7.5. To
remove the His tag, the recombinant protein was treated with
150 lL of resin-coupled thrombin (Thrombin CleanCleave KITTM,
Sigma, Milan, Italy) per 1mg of protein with gentle shaking at
þ20 C overnight, according to the manufacturer's instructions.
Protein concentration was determined using the DC Protein
AssayTM (Bio-Rad, Berlin, Germany) with three different dilutions.
2.3. CA activity measurements and inhibition studies
An Applied Photophysics stopped-flow instrument has been used
for assaying the CA catalysed CO2 hydration activity
19. Phenol red
(at a concentration of 0.2mM) has been used as indicator, working
at the absorbance maximum of 557 nm, with 20mM Hepes (pH
7.6) or 20mM TRIS (pH 8.3) as buffers, and 20mM NaClO4 (for
maintaining constant the ionic strength). Perchlorate is not inhibit-
ing the enzyme at concentrations up to 100mM, data not shown,
as for many other CAs investigated earlier by our group20), follow-
ing the initial rates of the CA-catalysed CO2 hydration reaction for
a period of 10–100 s19. The CO2 concentrations ranged from 1.7 to
17mM for the determination of the kinetic parameters and inhib-
ition constants. For each inhibitor at least six traces of the initial
5–10% of the reaction have been used for determining the initial
velocity. The uncatalysed rates were determined in the same man-
ner and subtracted from the total observed rates. Stock solutions
of inhibitors (10mM) were prepared in distilled-deionised water
and dilutions up to 0.01 nM were done thereafter with the assay
buffer. Inhibitor and enzyme solutions were preincubated together
for 15min at room temperature prior to assay, in order to allow
for the formation of the E-I complex. The inhibition constants
were obtained by non-linear least-squares methods using PRISM 3
and the Cheng–Prusoff equation, as reported earlier21–23, and rep-
resent the mean from at least three different determinations. All
CA isoforms were recombinant ones obtained in house as
reported earlier9,16. The concentration of AgaCA used in the
experiments reported in the paper was of 13.2 nM.
3. Results and discussion
As shown in the introduction, there exists only few studies on
insect CAs. Apart our initial reports9,16 on the presence of a b-CA
in Drosophila melanogaster and Anopheles gambiae, some sul-
phonamide and dithiocarbamate studies were reported for the
inhibition of the first enzyme24, but no other inhibition studies
(except the sulphonamide ones)16 are available for AgaCA. It
should be mentioned that recently a CA was also reported and its
activity/inhibition investigated from another insect species, the
honey bee Apis mellifera25. In this paper, we report the first exten-
sive anion inhibition study of the b-CA from Anopheles gambiae,
AgaCA, with a large series of simple and complex anions.
In the previous work16, we observed that AgaCA has a sig-
nificant catalytic activity for the physiologic, CO2 hydration reac-
tion to bicarbonate and protons, with the kinetic parameters
shown in Table 1. AgaCA has a catalytic activity which is simi-
lar to that of the human cytosolic isoform hCA I, and is also
inhibited quite effectively by the sulphonamide. The widely clin-
ically used compound, acetazolamide (5-acetamido-1,3,4-thiadia-
zole-2-sulphonamide), showed an inhibition constant of 27.3 nM
(Table 1).
Inorganic anions constitute an important class of CA inhibitors
(CAIs)20. Both inorganic, complexing anions and more complex
anions were investigated for their interaction with a large number
of enzymes belonging to all CA families20. Such studies may lead
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to the discovery of novel classes of pharmacologically relevant
CAIs: indeed, the dithiocarbamates were discovered, considering
the simple anion trithiocarbonate (CS3
2) as an inhibitor, and
showed significant in vitro and in vivo activities in pathologies
related to CA dysregulation, such as glaucoma26.
In Table 2, the inhibition of AgaCA with a panel of such anions
is shown. Inhibition data for the widespread cytosolic isoforms
hCA I and II, as well as for the enzyme from D. melanogaster, are
also shown, for comparison reasons. The following may be noted
from the inhibition data of Table 2:
(i) Anions with low propensity for inhibiting AgaCA were brom-
ide, iodide, bisulphite, perchlorate, perrhenate, perruthenate, and
peroxydisulphate, which showed KIs> 200mM. Whereas perchlo-
rate is generally the anion with less affinity for metal ions in solu-
tion and metalloenzyme (in fact it does not inhibit significantly
any CA investigated so far)20, the data for the heavy halogenides
and bisulphite are rather surprising, considering the fact that iod-
ide and bromide are rather effective hCA I and DmBCA inhibitors
(Table 2). Bisulphite is a weak hCA I and II inhibitor but it is more
effective as a DmBCA inhibitor.
(ii) Azide and hydrogensulphide, anions which show a high
affinity for many metal ions20, were rather weak AgaCA inhibitors,
with KIs of 12.4–25.1mM. They were much more effective as
DmBCA inhibitors and are micromolar hCA I inhibitors (Table 2).
Thus, there are significant differences in the affinity of these
inhibitors for various CAs, with the mosquito enzyme definitely
less sensitive to these inhibitors compared to other insect or
human CAs.
(iii) Most of the investigated anions showed inhibition con-
stants in the range of 1.80–9.46mM, being thus weak CAIs, but
normally this is the range in which most simple/complex anions
interact with most CAs20. They include fluoride, chloride, cyanate,
thiocyanate, cyanide, bicarbonate, carbonate, nitrite, nitrate, sul-
phate, stannate, selenate, tellurate, diphosphate, divanadate, tetra-
borate, selenocyanide, and trithiocarbonate (Table 2). It should be
observed that this series includes both anions with a high affinity
for complexing metal ions (such as cyanate, thiocyanate, and cyan-
ide) as well as anions with lower affinity for cations, such as nitrite,
nitrate, and sulphate. It is interesting to note that for the halogen-
ides, those incorporating light elements (F, Cl) were more effective
than the halogenides incorporating heavy elements, which is
opposite to the inhibitory effects observed with these anions
against hCA I and II (Table 2). Bicarbonate was two times better as
a AgaCA inhibitor compared with carbonate, whereas sulphate,
which is a weak hCA I and II inhibitor, showed a <10mM activity
against AgaCA.
(iii) N,N-Diethyldithiocarbamate was a submillimolar AgaCA
inhibitor, with a KI of 0.65mM, being thus much more effective
than trithiocarbonate (KI of 8.19mM) from which it is derived.
(iv) The most effective AgaCA inhibitors were sulphamide, sul-
phamic acid, phenylboronic acid, and phenylarsonic acid, with
inhibition constants in the range of 21–84mM. These compounds
are known to act as efficient CAIs against many CAs and were
used as leads to obtain potent inhibitors, some of which inhibit
these enzymes in the low nanomolar range27. Indeed, these simple
molecules incorporate zinc-binding functions of the sulphonamide,
sulphamide, sulphamate, boronic acid, etc., which have been
extensively employed to design highly effective CAIs27.
4. Conclusions
We report here an anion inhibition study of the b-class CA, AgaCA,
from the mosquito Anopheles gambiae, the vector responsible of
malaria transmission. A series of simple as well as complex inor-
ganic anions, together with small molecules known to interact
with CAs were included in the study. Bromide, iodide, bisulphite,
perchlorate, perrhenate, perruthenate, and peroxydisulphate were
ineffective AgaCA inhibitors, with KIs> 200mM. Fluoride, chloride,
cyanate, thiocyanate, cyanide, bicarbonate, carbonate, nitrite,
nitrate, sulphate, stannate, selenate, tellurate, diphosphate, divana-
date, tetraborate, selenocyanide, and trithiocarbonate showed KIs
Table 2. Inhibition constants of anionic inhibitors against isozymes hCA I, II
(a-CA class), and DmBCA (D. melanogaster) and AgaCA (A. gambiae) for the CO2
hydration reaction, at 20 C19.
KI [mM]
e
Inhibitor hCA Ia hCA IIa DmBCAb AgaCAc
F >300 >300 0.80 9.42
Cl 6 200 0.97 8.74
Br 4 63 1.04 >200
I 0.3 26 1.18 >200
CNO 0.0007 0.03 0.73 9.46
SCN 0.2 1.6 1.28 6.41
CN 0.0005 0.02 0.67 8.34
N3
 0.0012 1.5 1.12 12.40
HCO3
 12 85 26.90 4.34
CO3
2 15 73 0.86 9.25
NO3
 7 35 43.74 6.50
NO2
 8.4 63 28.60 4.55
HS 0.0006 0.04 1.01 25.10
HSO3
 18 89 1.29 >200
SO4
2 63 >200 1.36 9.03
ClO4
 >200 >200 >200 >200
SnO3
2 0.57 0.83 nt 1.80
SeO4
2 118 112 nt 9.41
TeO4
2 0.66 0.92 nt 4.96
P2O7
4 25.8 48.5 nt 8.52
V2O7
4 0.54 0.57 nt 7.98
B4O7
2 0.64 0.95 nt 7.95
ReO4 0.11 0.75 nt >200
RuO4 0.10 0.69 nt >200
S2O8
2 0.11 0.084 nt >200
SeCN 0.0085 0.086 nt 8.68
CS3
2 0.0087 0.0088 nt 8.19
Et2NCS2
 0.79 3.1 nt 0.65
H2NSO2NH2 0.31 1.13 0.15 0.054
H2NSO3H
d 0.021 0.39 2.45 0.021
Ph-B(OH)2 58.6 23.1 22.39 0.047
Ph-AsO3H2
d 31.7 49.2 32.60 0.084
aFrom ref.20a.
bFrom ref.9.
cThis work.
dAs sodium salt; nt: not tested.
eErrors in the range of 5–10% of the shown data, from three different assays, by
a CO2 hydration stopped-flow assay
19.
Table 1. Kinetic parameters for the CO2 hydration reaction catalysed by the
human cytosolic isozymes hCA I and II (a-class CAs) and the b-CAs from
Drosophila melanogaster (DmBCA) and Anopheles gambiae (AgaCA) measured at
20 C, pH 7.6 in 20mM HEPES buffer (for hCA I and II) and 20 C, pH 8.3 in
20mM TRIS buffer (for the b-CAs), in the presence 20mM NaClO4 (for maintain-
ing constant ionic strength). Inhibition data with the clinically used sulphona-
mide acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulphonamide) are also
provided.
Enzyme Activity level Class kcat (s
1)
kcat/Km
(M1 s1)
KI (acetazolamide)
(nM)
hCA Ia Moderate a 2.0 105 5.0 107 250
hCA IIa Very high a 1.4 106 1.5 108 12
DmBCAb High b 9.5 105 1.1 108 516
AgaCAc Moderate b 7.2 105 5.6 107 27.3
aFrom ref.20a.
bFrom ref.9.
cFrom ref.16.
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in the range of 1.80–9.46mM, whereas N,N-diethyldithiocarbamate
was a submillimolar AgaCA inhibitor, with a KI of 0.65mM. The
most effective AgaCA inhibitors were sulphamide, sulphamic acid,
phenylboronic acid, and phenylarsonic acid, with inhibition con-
stants in the range of 21–84 mM. The control of insect vectors
responsible of the transmission of many protozoan diseases is
rather difficult nowadays, and finding agents which can interfere
with these processes, as the enzyme inhibitors investigated here,
may arrest the spread of these diseases worldwide.
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